IP Verse

Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof - EP3054929

The patent EP3054929 was granted to Impax Laboratories on Aug 5, 2020. The application was originally filed on Oct 7, 2014 under application number EP14851749A. The patent is currently recorded with a legal status of "Revoked".

EP3054929

IMPAX LABORATORIES
Application Number
EP14851749A
Filing Date
Oct 7, 2014
Status
Revoked
May 14, 2025
Grant Date
Aug 5, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LUIGIMay 5, 2021TER MEER STEINMEISTER & PARTNERADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2508174
DESCRIPTIONUS2013195973
DESCRIPTIONWO2007002518
INTERNATIONAL-SEARCH-REPORTUS2002155154
INTERNATIONAL-SEARCH-REPORTUS2003152628
INTERNATIONAL-SEARCH-REPORTUS2009004229
INTERNATIONAL-SEARCH-REPORTUS2011111024
INTERNATIONAL-SEARCH-REPORTUS2012177731
OPPOSITIONUS2006004865
OPPOSITIONUS2007003621
OPPOSITIONUS2010298268
OPPOSITIONUS2013195973
OPPOSITIONWO2015054302
SEARCHEP2508174
SEARCHUS2013195973
SEARCHWO2007002518

Non-Patent Literature (NPL) Citations (2) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Anonymous, "SINEMET® CR (carbidopa levodopa)", FDA, (20110103), FDA, (20220823), XP055953949
OPPOSITION- Anonymous, "Stalevo 50, 75, 100, 125, 150, 200 mg (carbidopa, levodopa and entacapone) Tablets", Novartis - Prescribing information, (20080401), Novartis - Prescribing information, (20220823), XP055953952

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents